CVEO

Civeo Corporation

60
Fundamentals69/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential24/ 100

CVEO has the edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

CVEO Fundamentals

MetricStatus
Healthy
Stable
Healthy
Stable

CVEO's revenue and cash flow are currently healthy, and its profitability and balance sheet are stable.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

CVEO PE Valuation

CVEO has no meaningful PE right now: it lost money over the past year.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

CVEO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Stable
Limited
Low

Analysts expect CVEO's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

RKLB has the edge over CVEO on the outlook, with more favorable profitability expectations.

CVEO Risk to reward

ScenarioChangePrice
Upside+32%$48.10
Downside-24%$27.58

Calculated from the latest close: $36.33 on Nov 12.

CVEO trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than CVEO, with more potential upside relative to its potential downside.

CVEO Earnings Per Share

Q4 2023: $2.01Q1 2024: $2.08Q2 2024: $2.34Q3 2024: $1.37Q4 2024: $-1.19Q1 2025: $-1.56Q2 2025: $-2.37Q3 2025: $-2.05Q4 2025: $-1.59Q1 2026: $-1.21Q2 2026: $-1.19Q3 2026: $-0.65
Q4 2023: $2.01Q1 2024: $2.08Q2 2024: $2.34Q3 2024: $1.37Q4 2024: $-1.19Q1 2025: $-1.56Q2 2025: $-2.37Q3 2025: $-2.05Q4 2025: $-1.59Q1 2026: $-1.21Q2 2026: $-1.19Q3 2026: $-0.65
QuarterTTM EPSYoY
Q3 2026-$0.65+$1.40
Q2 2026-$1.19+$1.18
Q1 2026-$1.21+$0.35
Q4 2025-$1.59-$0.40
Q3 2025-$2.05-250%
Q2 2025-$2.37-201%
Q1 2025-$1.56-175%
Q4 2024-$1.19-159%

CVEO is still losing money, but far less than before: $0.65 per share over the past year, against $13.56 at its worst in early 2020.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB has the edge over CVEO on earnings, with more consistent year-over-year improvement.

CVEO Quarterly Revenue

Q4 2023: $171MQ1 2024: $166MQ2 2024: $189MQ3 2024: $176MQ4 2024: $151MQ1 2025: $144MQ2 2025: $163MQ3 2025: $170MQ4 2025: $162MQ1 2026: $173MQ2 2026: $180MQ3 2026: $193M
Q4 2023: $171MQ1 2024: $166MQ2 2024: $189MQ3 2024: $176MQ4 2024: $151MQ1 2025: $144MQ2 2025: $163MQ3 2025: $170MQ4 2025: $162MQ1 2026: $173MQ2 2026: $180MQ3 2026: $193M
QuarterRevenueYoY
Q3 2026$193.1M+13%
Q2 2026$180M+11%
Q1 2026$172.7M+20%
Q4 2025$161.6M+7.1%
Q3 2025$170.5M-3.3%
Q2 2025$162.7M-14%
Q1 2025$144M-13%
Q4 2024$151M-12%

CVEO's revenue has grown year over year for four quarters in a row: $193M last quarter, up 13% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over CVEO on sales, with more consistent year-over-year improvement.

CVEO Free Cash Flow

Q4 2023: $30MQ1 2024: $372,000Q2 2024: $27MQ3 2024: $28MQ4 2024: $2MQ1 2025: −$14MQ2 2025: −$7MQ3 2025: $8MQ4 2025: $14MQ1 2026: −$14MQ2 2026: $8MQ3 2026: $21M
Q4 2023: $30MQ1 2024: $372,000Q2 2024: $27MQ3 2024: $28MQ4 2024: $2MQ1 2025: −$14MQ2 2025: −$7MQ3 2025: $8MQ4 2025: $14MQ1 2026: −$14MQ2 2026: $8MQ3 2026: $21M
QuarterFree cash flowYoY
Q3 2026$21M+156%
Q2 2026$7.9M+$14.7M
Q1 2026-$13.9M-$161K
Q4 2025$14.5M+720%
Q3 2025$8.2M-71%
Q2 2025-$6.8M-125%
Q1 2025-$13.7M-3787%
Q4 2024$1.8M-94%

CVEO has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

CVEO Total Shares

Q4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 14MQ4 2024: 14MQ1 2025: 14MQ2 2025: 13MQ3 2025: 12MQ4 2025: 13MQ1 2026: 11MQ2 2026: 11MQ3 2026: 10M
Q4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 14MQ4 2024: 14MQ1 2025: 14MQ2 2025: 13MQ3 2025: 12MQ4 2025: 13MQ1 2026: 11MQ2 2026: 11MQ3 2026: 10M
PeriodChange %Net change
Quarterly-5%-551K shares
1 year-16%-2M shares
3 years-30%-4.5M shares
5 years-28%-4M shares
Available history-25%-3.5M shares

CVEO has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

CVEO Net Leverage

Q4 2023: 0.5xQ1 2024: 0.6xQ2 2024: 0.4xQ3 2024: 0.3xQ4 2024: 0.6xQ1 2025: 0.9xQ2 2025: 2.8xQ3 2025: 2.7xQ4 2025: 2.2xQ1 2026: 2.3xQ2 2026: 2.2xQ3 2026: 2.1x
Q4 2023: 0.5xQ1 2024: 0.6xQ2 2024: 0.4xQ3 2024: 0.3xQ4 2024: 0.6xQ1 2025: 0.9xQ2 2025: 2.8xQ3 2025: 2.7xQ4 2025: 2.2xQ1 2026: 2.3xQ2 2026: 2.2xQ3 2026: 2.1x
QuarterNet LeverageStatus
Q3 20262.1xModerate
Q2 20262.2xModerate
Q1 20262.3xModerate
Q4 20252.2xModerate
Q3 20252.7xModerate
Q2 20252.8xModerate
Q1 20250.9xVery low
Q4 20240.6xVery low

CVEO's net debt is about 2.1 years of its operating earnings (EBITDA), down from 2.7 years a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CVEO Weekly Momentum

MetricValueStatus
RSI58.6Neutral
Stochastic77.0Neutral

CVEO's weekly RSI is 59 (neutral) and its Stochastic is 77 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

CVEO PE vs Industrials Sector

MetricCVEOSector medianRelative
PEN/A24x—

CVEO has no meaningful PE right now: it lost money over the past year.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

CVEO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$32.711% above
20 week MA$32.910% above
50 week MA$30.320% above
100 week MA$26.438% above
200 week MA$25.046% above

CVEO has the edge over RKLB on trend strength, trading above more of its moving averages.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

CVEO Yearly ROI

YearStart priceEnd priceROI
2020$16.2$15.1-6.7%
2021$15.1$18.8+24%
2022$18.8$31.5+67%
2023$31.5$22.9-27%
2024$22.9$22.2-2.8%
2025$22.2$23.3+4.9%
2026 YTD$23.3$36.3+56%

CVEO has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key